COVID-19 Feature Products
ACE Biolabs
The detection kit can detect as well as identify RBD antigen of COVID-19 (SARS-CoV-2) virus in aquatic products, e.g. fish and shrimp, livestock, e.g. pigs, cattle and sheep, and the environment by using colloidal gold immunochromatography. The reagent pad contains anti-COVID-19 (SARS-CoV-2) virus RBD antibody conjugated with colloidal gold particles and the secondary antibody against anti-COVID-19 (SARS-CoV-2) virus RBD antibody are immobilized in a line across the reaction membrane as a test line (T line). The COVID-19 (SARS-CoV-2) virus RBD is first captured by colloidal gold conjugated anti-RBD antibody and the antigen-antibody-conjugate complex is formed during testing process. The Ag-Ab complex then is detected by the secondary antibody coated on the T line while migrates across the reaction membrane and a visible pink signal band is formed. If there is no COVID-19 (SARS-CoV-2) virus RBD antigen contained in the sample, no pink band will appear at the T line. The quality control line (C line) on the reaction membrane is an indicator of product effectiveness. No matter whether the signal at T line appears or not, a pink line should always appear at C line. If no pink signal is shown at C line, it indicated that the test result is invalid and additional testing is required.
This testing kit uses RT-LAMP (Reverse Transcription-Loop-mediated Isothermal Amplification) technology combining visualizing method to perform amplification detection of the RBD region in COVID-19 (SARS-CoV-2) virus RNA, which can detect and identify the RBD antigen of COVID-19 (SARS-CoV-2) virus in aquatic products, e.g. fish and shrimp, livestock, e.g. pigs, cattle and sheep, and the environment.
This product is a multiplex fluorescent probe-based Taqman® RT-qPCR assay system. This product provides triplex-detections in a single tube, including two independent genes of COVID-19 (SARS-CoV-2) virus and an internal control which targets the human RNAse P (RNP) gene to assess specimen quality.
This kit contains essential reagents for the development of COVID-19 IgG/IgM Lateral Flow (Rapid Test) assay to help with the qualitative detection of IgG and IgM antibodies specific to SARS-CoV-2 in human biological fluids.
researches on COVID-19 have reported highly relation between COVID-19 virus infection and cytokine storm.
ACE Biolabs is actively in the process of developing COVID-19 IgG/IgM Dual Detection Kits (Colloidal Gold-Based) and providing raw materials of diagnostic detection kit, such as SARS-CoV-2 antigens (Nucleocapsid protein and Spike protein), Anti-SARS-CoV-2 antibodies (anti-NP and anti-S), Pseudovirus and RT-qPCR reagents.
ACE Biolabs used the lentiviral packaging system to package the SARS-CoV-2 (2019-nCoV, COVID-19 virus) S protein as a surface capsid glycoprotein and containing GFP and Luciferase dual reporter genes as a pseudovirus model. The virus can infect cell lines overexpressing the ACE2 gene. Researchers can determine the infection efficiency by observing GFP through a microscope and detecting the value of Luciferase.
.jpg)
.png)
